Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Basal Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Early research (Phase 1)Study completedNCT03889912
What this trial is testing

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 97
Testing effectiveness (Phase 2)Temporarily pausedNCT05929664
What this trial is testing

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Who this might be right for
Locally Advanced Basal Cell CarcinomaBasal Cell Carcinoma
Thomas Jefferson University 70
Not applicableStudy completedNCT00218868
What this trial is testing

Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear

Who this might be right for
Carcinoma, Basal CellPorokeratosis, Disseminated Superficial Actinic
Norwegian University of Science and Technology 66
Testing effectiveness (Phase 2)WithdrawnNCT00025051
What this trial is testing

Celecoxib in Preventing Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT04389112
What this trial is testing

Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinomas
University Hospital, Bordeaux 119
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07227870
What this trial is testing

L19IL2/TNF in Patients With Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 92
Not applicableUnknownNCT01265472
What this trial is testing

Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy

Who this might be right for
Squamous Cell CarcinomaBasal Cell Carcinoma
Rambam Health Care Campus 100
Not applicableLooking for participantsNCT04068155
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Who this might be right for
Skin CancerCutaneous TumorCutaneous Metastasis
Alpha Tau Medical LTD. 80
Early research (Phase 1)UnknownNCT00391300
What this trial is testing

Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
Eastern Virginia Medical School 100
Very early researchActive Not RecruitingNCT07144384
What this trial is testing

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Who this might be right for
Skin Basal Cell CarcinomaSkin Nodular Basal Cell CarcinomaSkin Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 4
Not applicableActive Not RecruitingNCT06014619
What this trial is testing

Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs

Who this might be right for
Skin CancerComplicationComplication of Surgical Procedure+7 more
Maastricht University Medical Center 500
Early research (Phase 1)Looking for participantsNCT07600476
What this trial is testing

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaMucosal MelanomaCutaneous Squamous Cell Carcinoma (CSCC)+2 more
Kupando GmbH 21
Not applicableActive Not RecruitingNCT05724875
What this trial is testing

FLASH Radiotherapy for Skin Cancer

Who this might be right for
Basal Cell CarcinomaCutaneous Squamous Cell Carcinoma
Centre Hospitalier Universitaire Vaudois 60
Early research (Phase 1)Study completedNCT00784108
What this trial is testing

Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.

Who this might be right for
Skin CancerSigns and Symptoms
University of California, Irvine 11
Not applicableUnknownNCT05340543
What this trial is testing

Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)

Who this might be right for
Cutaneous TumorOptical Coherence TomographyBasal Cell Carcinoma+2 more
GCS Ramsay Santé pour l'Enseignement et la Recherche 150
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Not applicableUnknownNCT05550766
What this trial is testing

Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma

Who this might be right for
Non-melanoma Skin Cancer
Sohag University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07227350
What this trial is testing

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 180
Next Page